Evaluation of the Dade Behring Syva EMIT 2000 tacrolimus assay on the Bayer Advia 1650

D. W. Stephen, Patrick Hugh Rooney, S. Clark, M. Coutts, L. Crowe, D. Docherty

    Research output: Contribution to journalArticle

    8 Citations (Scopus)

    Abstract

    Background The Dade Behring Syva(R) EMIT (enzyme multiplied immunoassay technique) method for the measurement of tacrolimus in whole blood was evaluated against the Abbott IMx(R) microparticle enzyme immunoassay (MEIA) method. EMIT measures tacrolimus colorimetrically, whereas MEIA measures the analyte using fluorimetry. Both methods incorporate a protein precipitation step prior to measurement.

    Method Whole blood specimens were treated by two types of precipitation technique followed by analysis for tacrolimus by either MEIA or EMIT on the Bayer Advia 1650. Linearity and precision were assessed and correlation analysis performed to evaluate the EMIT assay on the Bayer Advia 1650.

    Results The EMIT tacrolimus assay was linear over the concentration range 0.0-22.0 mug/L; the limit of detection was 1.2 mug/L. Correlation between the Syva EMIT and IMx tacrolimus assays was excellent (r=0.959) and no significant bias existed between the two methods (mean difference, delta = 0.221 mug/L). Calibration data for the EMIT assay was stable for a period of 24-48 h on the Advia between runs.

    Conclusion The Syva EMIT assay for the measurement of tacrolimus in whole blood is suited for daily routine use on the Bayer Advia 1650.

    Original languageEnglish
    Pages (from-to)697-700
    Number of pages3
    JournalAnnals of Clinical Biochemistry
    Volume40
    Issue numberPt 6
    DOIs
    Publication statusPublished - 2003

    Keywords

    • FK-506
    • BLOOD
    • FK506

    Cite this

    Stephen, D. W., Rooney, P. H., Clark, S., Coutts, M., Crowe, L., & Docherty, D. (2003). Evaluation of the Dade Behring Syva EMIT 2000 tacrolimus assay on the Bayer Advia 1650. Annals of Clinical Biochemistry, 40(Pt 6), 697-700. https://doi.org/10.1258/000456303770367333

    Evaluation of the Dade Behring Syva EMIT 2000 tacrolimus assay on the Bayer Advia 1650. / Stephen, D. W.; Rooney, Patrick Hugh; Clark, S.; Coutts, M.; Crowe, L.; Docherty, D.

    In: Annals of Clinical Biochemistry, Vol. 40, No. Pt 6, 2003, p. 697-700.

    Research output: Contribution to journalArticle

    Stephen, DW, Rooney, PH, Clark, S, Coutts, M, Crowe, L & Docherty, D 2003, 'Evaluation of the Dade Behring Syva EMIT 2000 tacrolimus assay on the Bayer Advia 1650', Annals of Clinical Biochemistry, vol. 40, no. Pt 6, pp. 697-700. https://doi.org/10.1258/000456303770367333
    Stephen, D. W. ; Rooney, Patrick Hugh ; Clark, S. ; Coutts, M. ; Crowe, L. ; Docherty, D. / Evaluation of the Dade Behring Syva EMIT 2000 tacrolimus assay on the Bayer Advia 1650. In: Annals of Clinical Biochemistry. 2003 ; Vol. 40, No. Pt 6. pp. 697-700.
    @article{d2e061eb4b2e4264b93cb8106a526a50,
    title = "Evaluation of the Dade Behring Syva EMIT 2000 tacrolimus assay on the Bayer Advia 1650",
    abstract = "Background The Dade Behring Syva(R) EMIT (enzyme multiplied immunoassay technique) method for the measurement of tacrolimus in whole blood was evaluated against the Abbott IMx(R) microparticle enzyme immunoassay (MEIA) method. EMIT measures tacrolimus colorimetrically, whereas MEIA measures the analyte using fluorimetry. Both methods incorporate a protein precipitation step prior to measurement.Method Whole blood specimens were treated by two types of precipitation technique followed by analysis for tacrolimus by either MEIA or EMIT on the Bayer Advia 1650. Linearity and precision were assessed and correlation analysis performed to evaluate the EMIT assay on the Bayer Advia 1650.Results The EMIT tacrolimus assay was linear over the concentration range 0.0-22.0 mug/L; the limit of detection was 1.2 mug/L. Correlation between the Syva EMIT and IMx tacrolimus assays was excellent (r=0.959) and no significant bias existed between the two methods (mean difference, delta = 0.221 mug/L). Calibration data for the EMIT assay was stable for a period of 24-48 h on the Advia between runs.Conclusion The Syva EMIT assay for the measurement of tacrolimus in whole blood is suited for daily routine use on the Bayer Advia 1650.",
    keywords = "FK-506, BLOOD, FK506",
    author = "Stephen, {D. W.} and Rooney, {Patrick Hugh} and S. Clark and M. Coutts and L. Crowe and D. Docherty",
    year = "2003",
    doi = "10.1258/000456303770367333",
    language = "English",
    volume = "40",
    pages = "697--700",
    journal = "Annals of Clinical Biochemistry",
    issn = "0004-5632",
    publisher = "SAGE Publications Ltd",
    number = "Pt 6",

    }

    TY - JOUR

    T1 - Evaluation of the Dade Behring Syva EMIT 2000 tacrolimus assay on the Bayer Advia 1650

    AU - Stephen, D. W.

    AU - Rooney, Patrick Hugh

    AU - Clark, S.

    AU - Coutts, M.

    AU - Crowe, L.

    AU - Docherty, D.

    PY - 2003

    Y1 - 2003

    N2 - Background The Dade Behring Syva(R) EMIT (enzyme multiplied immunoassay technique) method for the measurement of tacrolimus in whole blood was evaluated against the Abbott IMx(R) microparticle enzyme immunoassay (MEIA) method. EMIT measures tacrolimus colorimetrically, whereas MEIA measures the analyte using fluorimetry. Both methods incorporate a protein precipitation step prior to measurement.Method Whole blood specimens were treated by two types of precipitation technique followed by analysis for tacrolimus by either MEIA or EMIT on the Bayer Advia 1650. Linearity and precision were assessed and correlation analysis performed to evaluate the EMIT assay on the Bayer Advia 1650.Results The EMIT tacrolimus assay was linear over the concentration range 0.0-22.0 mug/L; the limit of detection was 1.2 mug/L. Correlation between the Syva EMIT and IMx tacrolimus assays was excellent (r=0.959) and no significant bias existed between the two methods (mean difference, delta = 0.221 mug/L). Calibration data for the EMIT assay was stable for a period of 24-48 h on the Advia between runs.Conclusion The Syva EMIT assay for the measurement of tacrolimus in whole blood is suited for daily routine use on the Bayer Advia 1650.

    AB - Background The Dade Behring Syva(R) EMIT (enzyme multiplied immunoassay technique) method for the measurement of tacrolimus in whole blood was evaluated against the Abbott IMx(R) microparticle enzyme immunoassay (MEIA) method. EMIT measures tacrolimus colorimetrically, whereas MEIA measures the analyte using fluorimetry. Both methods incorporate a protein precipitation step prior to measurement.Method Whole blood specimens were treated by two types of precipitation technique followed by analysis for tacrolimus by either MEIA or EMIT on the Bayer Advia 1650. Linearity and precision were assessed and correlation analysis performed to evaluate the EMIT assay on the Bayer Advia 1650.Results The EMIT tacrolimus assay was linear over the concentration range 0.0-22.0 mug/L; the limit of detection was 1.2 mug/L. Correlation between the Syva EMIT and IMx tacrolimus assays was excellent (r=0.959) and no significant bias existed between the two methods (mean difference, delta = 0.221 mug/L). Calibration data for the EMIT assay was stable for a period of 24-48 h on the Advia between runs.Conclusion The Syva EMIT assay for the measurement of tacrolimus in whole blood is suited for daily routine use on the Bayer Advia 1650.

    KW - FK-506

    KW - BLOOD

    KW - FK506

    U2 - 10.1258/000456303770367333

    DO - 10.1258/000456303770367333

    M3 - Article

    VL - 40

    SP - 697

    EP - 700

    JO - Annals of Clinical Biochemistry

    JF - Annals of Clinical Biochemistry

    SN - 0004-5632

    IS - Pt 6

    ER -